males or females, aged ≥ 18 years at time of consent.
Item
males or females, aged ≥ 18 years at time of consent.
boolean
C0086582 (UMLS CUI [1,1])
C0001779 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,4])
C0086287 (UMLS CUI [2,1])
C0001779 (UMLS CUI [2,2])
C0347984 (UMLS CUI [2,3])
C0021430 (UMLS CUI [2,4])
diagnosis of psoriatic arthritis (psa, by any criteria) of ≥ 6 months duration.
Item
have a diagnosis of psoriatic arthritis (psa, by any criteria) of ≥ 6 months duration.
boolean
C0003872 (UMLS CUI [1,1])
C0011900 (UMLS CUI [1,2])
C0243161 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,4])
meet the classification criteria for psoriatic arthritis (caspar) at time of screening.
Item
meet the classification criteria for psoriatic arthritis (caspar) at time of screening.
boolean
C0003872 (UMLS CUI [1,1])
C0008902 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
C0347984 (UMLS CUI [1,4])
C0220908 (UMLS CUI [1,5])
inadequately treated by disease-modifying antirheumatic drugs
Item
must have been inadequately treated by disease-modifying antirheumatic drugs (dmards)
boolean
C0087111 (UMLS CUI [1,1])
C0242708 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
may not have axial involvement alone
Item
may not have axial involvement alone
boolean
C0475264 (UMLS CUI [1,1])
C0205131 (UMLS CUI [1,2])
C1548966 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
concurrent treatment allowed with methotrexate, leflunomide, or sulfasalazine
Item
concurrent treatment allowed with methotrexate, leflunomide, or sulfasalazine
boolean
C0025677 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205420 (UMLS CUI [1,3])
C0683607 (UMLS CUI [1,4])
C0063041 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0205420 (UMLS CUI [2,3])
C0683607 (UMLS CUI [2,4])
C0036078 (UMLS CUI [3,1])
C0087111 (UMLS CUI [3,2])
C0205420 (UMLS CUI [3,3])
C0683607 (UMLS CUI [3,4])
have ≥ 3 swollen and ≥ 3 tender joints.
Item
have ≥ 3 swollen and ≥ 3 tender joints.
boolean
C0451521 (UMLS CUI [1])
C0451530 (UMLS CUI [2])
males & females must use contraception
Item
males & females must use contraception
boolean
C0086582 (UMLS CUI [1,1])
C0420837 (UMLS CUI [1,2])
C0086287 (UMLS CUI [2,1])
C0420837 (UMLS CUI [2,2])
stable dose of nonsteroidal anti-inflammatory drugs (nsaids), narcotics and low dose oral corticosteroids allowed.
Item
stable dose of nonsteroidal anti-inflammatory drugs (nsaids), narcotics and low dose oral corticosteroids allowed.
boolean
C0003211 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0683607 (UMLS CUI [1,4])
C0027415 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0683607 (UMLS CUI [2,4])
C0038317 (UMLS CUI [3,1])
C0445550 (UMLS CUI [3,2])
C1527415 (UMLS CUI [3,3])
C0178602 (UMLS CUI [3,4])
C0205360 (UMLS CUI [3,5])
C0683607 (UMLS CUI [3,6])
pregnant or breast feeding.
Item
pregnant or breast feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
history of allergy to any component of the investigational product.
Item
history of allergy to any component of the investigational product.
boolean
C0262926 (UMLS CUI [1,1])
C0020517 (UMLS CUI [1,2])
C1705248 (UMLS CUI [1,3])
C0304229 (UMLS CUI [1,4])
hepatitis b surface antigen and/or hepatitis c antibody positive at screening.
Item
hepatitis b surface antigen and/or hepatitis c antibody positive at screening.
boolean
C0149709 (UMLS CUI [1,1])
C0220908 (UMLS CUI [1,2])
C0281863 (UMLS CUI [2,1])
C0220908 (UMLS CUI [2,2])
therapeutic failure on > 3 agents for psa or > 1 biologic tumor necrosis factor (tnf) blocker
Item
therapeutic failure on > 3 agents for psa or > 1 biologic tumor necrosis factor (tnf) blocker
boolean
C0162643 (UMLS CUI [1,1])
C0003872 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0750480 (UMLS CUI [1,4])
C0162643 (UMLS CUI [2,1])
C0281481 (UMLS CUI [2,2])
C0750480 (UMLS CUI [2,3])